![](https://endpts.com/wp-content/uploads/2021/06/mf-FE.jpg)
Manufacturing roundup: Catalent to produce low-cost version of naloxone; CSL opens R&D site
Catalent will be manufacturing a low-cost version of the opioid overdose treatment naloxone as part of a contract with Harm Reduction Therapeutics.
Catalent plans to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.